Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Troels Lillebaek is active.

Publication


Featured researches published by Troels Lillebaek.


American Journal of Tropical Medicine and Hygiene | 2011

Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study

Xinyu Zhang; Åse Bengård Andersen; Troels Lillebaek; Zaza Kamper-Jørgensen; Vibeke Østergaard Thomsen; Karin Ladefoged; Carl F. Marrs; Lixin Zhang; Zhenhua Yang

Extrapulmonary tuberculosis (EPTB) is an important health problem that may cause serious morbidity and diagnostic challenges. We conducted a case-control study involving 5,684, approximately 99% of bacteriologically confirmed TB patients (including 1,925 EPTB cases) diagnosed in Denmark and Greenland during 1992-2007 to gain insight to the role of host factors in EPTB pathogenesis. Among patients from Somalia and Asia, persons 25-44 and 45-64 years of age were more likely to have EPTB than persons 15-24 years of age. In contrast, among persons from Greenland, the two oldest age groups were significantly less likely to have EPTB than the youngest age group. For all the age groups, the odds for having EPTB was significantly higher among patients from Somalia and Asia and significantly lower among the patients from Greenland than among patients from Denmark. Furthermore, the occurrence of specific types of EPTB significantly varied among different age groups or origins.


Scandinavian Journal of Clinical & Laboratory Investigation | 2012

Antigen-induced cytokine and chemokine release test for tuberculosis infection using adsorption of stimulated whole blood on filter paper and multiplex analysis.

Kristin Skogstrand; Anna Hammerich Thysen; Charlotte Sværke Jørgensen; E. Michael Rasmussen; Åse Bengård Andersen; Troels Lillebaek; David M. Hougaard; Gunnar Houen

Background: In vitro stimulation of whole blood or isolated blood cells with specific antigens is used for several purposes. Immediately following incubation with antigens, samples have to be centrifuged to stop the reactions by remaining cells and the supernatant refrigerated or analysed directly to preserve the analytes of interest, which makes samples difficult to prepare outside laboratories. We have tested whether spotting whole blood on filter paper after activation can be used in one of the tests for Mycobacterium tuberculosis infection (MTI), the QuantiFERON®-TB Gold In Tube test (QFT), where the spotting technique can make it suitable for use in locations without facilities like a centrifuge and a refrigerator. Materials and methods: Samples from 22 individuals undergoing screening for MTI and 10 healthy controls were incubated, centrifuged and IFN-γ measured by Enzyme-linked immunosorbent assay (ELISA), as described in the kit insert. In parallel, activated blood was spotted on filter paper (Schleicher & Schuell) and dried. The dried blood spot samples were analysed for 21 inflammatory markers with an in-house assay based on Luminex technology. Results: Our multiplex measurements of inflammatory markers in samples from suspected MTI patients confirmed the IFN-γ findings in the QFT. IL-2, GM-CSF, IL-5, and IL-1β were also found as useful markers for MTI. We were not able to distinguish between active tuberculosis and latent MTI. Conclusion: Applying blood on filter paper after incubation makes in vitro stimulation tests feasible in locations where heat and electricity is unavailable.


Tuberculosis | 2009

Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique.

Troels Lillebaek; Winnie Bergstedt; Pernille N. Tingskov; Birgit Thierry-Carstensen; Henrik Aggerbeck; Soeren T. Hoff; Karin Weldingh; Peter Andersen; Bolette Soborg; Vibeke Østergaard Thomsen; Aase Bengaard Andersen

Limited specificity of the tuberculin skin test incited the development of the intradermal Mycobacterium tuberculosis-specific rdESAT-6 skin test. Animal studies have shown, however, that there is a possible risk of sensitization when repeated injections of rdESAT-6 are given. The aim of this phase 1 open clinical trial was to assess the sensitization risk and safety of repeated administration of rdESAT-6 reagent in 31 healthy adult volunteers. Three groups of volunteers received two fixed doses of 0.1 microg rdESAT-6 28, 56 or 112 days apart, respectively. After the second injection, the diameter of induration and/or redness at the injection site was measured and taken as a possible sensitization reaction if >5mm. In vitro interferon gamma (IFN-gamma) responses were measured as supportive evidence. Local adverse reactions at the injection site and adverse events were recorded. One out of 31 (3%) volunteers showed a positive skin reaction (sensitization) upon a second injection of rdESAT-6 after 28days and an increased IFN-gamma response to ESAT-6. For 7 (23%) of the volunteers, local adverse reactions related to the product were registered, but all reactions were mild and predictable. In conclusion, repeated injections of the rdESAT-6 skin test reagent are safe, and sensitization occurs at a low rate, especially if the time span between succeeding doses is wide.


Infection, Genetics and Evolution | 2011

How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology

Zhenhua Yang; Mariana Rosenthal; Noah A. Rosenberg; Sarah Talarico; Lixin Zhang; Carl F. Marrs; Vibeke Østergaard Thomsen; Troels Lillebaek; Åse Bengård Andersen

Mycobacterium tuberculosis may survive for decades in the human body in a state termed latent tuberculosis infection (LTBI). We investigated the occurrence during LTBI of insertion/deletion events in a selected set of mononucleotide simple sequence repeats, DNA sequence changes in four M. tuberculosis genes, and large sequence variations in 4750 M. tuberculosis open reading frames. We studied 13 paired M. tuberculosis clinical isolates, with each pair representing a reactivation of LTBI more than three decades after primary infection. Absence of sequence variations between paired isolates in nearly all investigated loci suggests a low likelihood of bacterial replication during LTBI.


Scandinavian Journal of Infectious Diseases | 2010

Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.

Didi Bang; Troels Lillebaek; Vibeke Østergaard Thomsen; Åse Bengård Andersen

Abstract A retrospective nationwide study including all culture-verified multidrug-resistant (MDR) tuberculosis (TB) cases was performed in Denmark. The aim was to examine the long-term treatment outcome of MDR-TB, to assess if MDR-TB transmission occurs, and to evaluate a rapid mutation analysis detecting rifampin and isoniazid resistance in this cohort. Clinical data were obtained from patient records. A restriction fragment length polymorphism genotype database of all TB cases was compared for identical strains indicating active transmission. Twenty-nine cases of MDR-TB were identified and the incidence was low at 0.5%. Acquired MDR-TB and active transmission was rare. Mutations in rifampin (rpoB) and isoniazid (katG, inhA) genes correctly determined resistance in 100% and 82% of all isolates tested, respectively. Initial treatment success was 89% for 27 MDR-TB patients with available outcome data. Initially 3 patients defaulted; no deaths were reported. Including successfully re-treated default patients and censoring patients who spent <2 y in the cohort, long-term treatment success was achieved for all 26 patients (mean follow-up 8.9 y). MDR-TB has a good prognosis in the high-income, low TB burden country of Denmark. Continued surveillance and rapid detection of resistance mutations directly in smear-positive patients may improve the standard of MDR-TB care.


Scandinavian Journal of Infectious Diseases | 2004

Tuberculosis not verified by culture in a low incidence country

J. P. Thyssen; Troels Lillebaek; Peter Andersen; A. Kok-Jensen; Vibeke Østergaard Thomsen

The objective was to evaluate the magnitude, diagnostic basis and characteristics of patients notified with tuberculosis (TB) not verified by culture. All patients in Denmark notified with TB between 1995 and 1999 were identified through the national TB register. Nationwide culture results were obtained from the International Reference Laboratory of Mycobacteriology. The proportion of culture verification decreased from 91% in 1995 to 80% in 1999. A total of 2518 patients were notified, of which 374 (14.9%) were not verified by culture. For 80 (3.2%) patients no specimens were submitted. Instead the diagnosis was mainly based on X-ray (72.6%) for patients with pulmonary TB and histology (38.3%) for patients with extrapulmonary TB. For 216 patients aged 0–14 y, 74 (34.3%) were not verified by culture. The proportion of TB not verified by culture in Denmark is low compared to other European countries. Some cases may be well explained, e.g. children with a close contact suffering from TB or patients with extrapulmonary TB with limited number of specimens. However, for a minority group of patients with pulmonary TB there were no obvious reasons why specimens were not submitted for culture. Culture verification should remain a priority when possible.


Clinical Respiratory Journal | 2009

Occupational tuberculosis following extremely short exposure

Zaza Kamper-Jørgensen; Troels Lillebaek; Åse Bengård Andersen

Introduction:u2002 Transmission of Mycobacterium tuberculosis (MT) in most cases requires extended exposure.


Ugeskrift for Læger | 2012

[Continued problems with tuberculosis among Danes and Greenlanders in Denmark and the need for reinforced control--a systematic review].

Troels Lillebaek; Åse Bengård Andersen; Seersholm Nj; Thomsen Vo


Ugeskrift for Læger | 2011

Behandling og diagnostik af tuberkulose: fremad med små skridt

Åse Bengård Andersen; Troels Lillebaek; Didi Bang; Julie B. Prahl


Ugeskrift for Læger | 2003

Tuberculosis and molecular biology

Åse Bengård Andersen; Troels Lillebaek; Søborg C; Isik Somuncu Johansen; Thomsen Vo

Collaboration


Dive into the Troels Lillebaek's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Didi Bang

Statens Serum Institut

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lixin Zhang

University of Michigan

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge